Amneal Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of AMRX for the last quarter is 702.47 M USD, and it's 0.10% higher compared to the previous quarter. The net income of Q3 24 is -156.00 k USD.